Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on MK-6194 for Adults with Systemic Lupus Erythematosus
FranceLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
AustriaStudy on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients
SwedenStudy on the Effects and Safety of Rilzabrutinib for Adults with Warm Autoimmune Hemolytic Anemia
DenmarkStudy on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy
IcelandStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
BelgiumStudy of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
SpainStudy on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease
GermanyStudy on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis
CzechiaStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
BelgiumStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
GermanyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
